Gene · 23645
Papers2,536
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,536
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Translational regulation by uORFs and start codon selection stringency. | Genes Dev | 2023 | 37433636 | PubTator, text mining | PubMed |
| An approach for prioritizing candidate genes from RNA-seq using preclinical cocaine self-administration datasets as a test case. | G3 (Bethesda) | 2023 | 37433118 | PubTator, text mining | PubMed |
| Biomolecular phase separation in stress granule assembly and virus infection. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37401177 | PubTator, text mining | PubMed |
| A tricarboxylic acid cycle-based machine learning model to select effective drug targets for the treatment of esophageal squamous cell carcinoma. | Front Pharmacol | 2023 | 37383713 | PubTator, text mining | PubMed |
| Onco-Pathogen Mediated Cancer Progression and Associated Signaling Pathways in Cancer Development. | Pathogens | 2023 | 37375460 | PubTator, text mining | PubMed |
| LncRNAs and CircRNAs in Endoplasmic Reticulum Stress: A Promising Target for Cardiovascular Disease? | Int J Mol Sci | 2023 | 37373035 | PubTator, text mining | PubMed |
| Inhibition of PERK Kinase, an Orchestrator of the Unfolded Protein Response (UPR), Significantly Reduces Apoptosis and Inflammation of Lung Epithelial Cells Triggered by SARS-CoV-2 ORF3a Protein. | Biomedicines | 2023 | 37371681 | PubTator, text mining | PubMed |
| NLRX1 functions as a tumor suppressor in Pan02 pancreatic cancer cells. | Front Oncol | 2023 | 37342194 | PubTator, text mining | PubMed |
| Glucose Hypometabolism Prompts RAN Translation and Exacerbates C9orf72-related ALS/FTD Phenotypes. | bioRxiv | 2023 | 37333144 | PubTator, text mining | PubMed |
| Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells. | Front Cell Infect Microbiol | 2023 | 37325516 | PubTator, text mining | PubMed |
| Differential In Vivo Effects on Cancer Models by Recorded Magnetic Signals Derived From a Healing Technique. | Dose Response | 2023 | 37325440 | PubTator, text mining | PubMed |
| Ubiquitin-like protein 5 is a novel player in the UPR-PERK arm and ER stress-induced cell death. | J Biol Chem | 2023 | 37315790 | PubTator, text mining | PubMed |
| Compromised nonsense-mediated RNA decay results in truncated RNA-binding protein production upon DUX4 expression. | Cell Rep | 2023 | 37314931 | PubTator, text mining | PubMed |
| Nuclear translocation of an aminoacyl-tRNA synthetase may mediate a chronic "integrated stress response". | Cell Rep | 2023 | 37314928 | PubTator, text mining | PubMed |
| Chronic cerebral hypoperfusion: a critical feature in unravelling the etiology of vascular cognitive impairment. | Acta Neuropathol Commun | 2023 | 37309012 | PubTator, text mining | PubMed |
| Leveraging single-cell RNA sequencing to unravel the impact of aging on stroke recovery mechanisms in mice. | Proc Natl Acad Sci U S A | 2023 | 37307473 | PubTator, text mining | PubMed |
| PERK signaling promotes mitochondrial elongation by remodeling membrane phosphatidic acid. | EMBO J | 2023 | 37306086 | PubTator, text mining | PubMed |
| Cell-based and cell-free immunotherapies for glioblastoma: current status and future directions. | Front Immunol | 2023 | 37304305 | PubTator, text mining | PubMed |
| The oxidative aging model integrated various risk factors in type 2 diabetes mellitus at system level. | Front Endocrinol (Lausanne) | 2023 | 37293508 | PubTator, text mining | PubMed |
| Transcriptomic and functional analysis of ANGPTL4 overexpression in pancreatic cancer nominates targets that reverse chemoresistance. | BMC Cancer | 2023 | 37291514 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23645/papers?page=12